ARCT: Arcturus Therapeutics Holdings Inc. Stock

by  •  • Comments Off on ARCT: Arcturus Therapeutics Holdings Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 339.82
Enterprise Value ($M) 137.87
Book Value ($M) 233.76
Book Value / Share 8.62
Price / Book 1.45
NCAV ($M) 180.77
NCAV / Share 6.67
Price / NCAV 1.88

Profitability (mra)
Return on Invested Capital (ROIC) -0.25
Return on Assets (ROA) -0.16
Return on Equity (ROE) -0.26

Liquidity (mrq)
Quick Ratio 5.64
Current Ratio 5.64

Balance Sheet (mrq) ($M)
Current Assets 278.79
Assets 331.79
Liabilities 98.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 152.31
Operating Income -95.67
Net Income -80.94
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -59.75
Cash from Investing -0.65
Cash from Financing 5.42

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-12 13G/A Nikko Asset Management Americas, Inc. 7.10 -16.81
04-25 13G/A Sumitomo Mitsui Trust Holdings, Inc. 7.10 -16.81
04-23 13G/A BlackRock, Inc. 7.80 -23.28
02-05 13G State Street Corp 4.90 -18.62

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 71,919 345,386 20.82
2025-05-29 92,111 380,190 24.23
2025-05-28 62,830 247,017 25.44
2025-05-27 42,526 247,940 17.15

(click for more detail)

Similar Companies
APGE – Apogee Therapeutics, Inc. APLT – Applied Therapeutics, Inc.
AQST – Aquestive Therapeutics, Inc. ARDX – Ardelyx, Inc.
ATAI – Atai Life Sciences N.V.


Financial data and stock pages provided by
Fintel.io